Nvidia's new $999 card earned our Editors' Choice award on the basis of its pure muscle, but I have a few very specific ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

In general, Amazon's approach is to be everything to everyone rather than striving for a niche audience, and it has released ...

In the long term, Sirius XM does face some serious headwinds. Remote work has put a dent in subscriber growth, as many ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Beijing hit back with its own tariffs and export restrictions after being subjected to levies by President Trump. Trade ...

What makes a stock go up? Supply and demand. More buyers means a rise in stock prices. When there are more sellers, stock ...

Elon Musk‘s latest comments on money make the same errors as we saw with Milton Friedman and the Monetarists. If Musk really wants to understand money, he needs ...

Nike (NYSE: NKE) has been a top stock to own throughout its history. However, the business has struggled in recent years, and ...

Gold’s monster upleg over this past year or so has proven remarkable, overcoming plenty of serious challenges.